Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues ...

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...

There is some promising news for pancreatic cancer research, as medical data show lasting results from the trial of a vaccine ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

The novel personalized mRNA vaccine also demonstrates the potential for such vaccines in other solid tumor types.

Moderna moved its H5N1 vaccine candidate into the first late-stage human trial for a pandemic bird flu shot made with mRNA ...

By Blake Brittain April 24 (Reuters) - German biotech company CureVac sued Moderna in Delaware federal court on Friday, ...

The new trial makes mRNA vaccines personalized, taking an individual’s unique tumor cells. Seven out of the study’s eight ...

Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat. CAMBRIDGE, MA / ACC ...

The first participants in the UK and US have received Moderna’s mRNA-1018 vaccine in a phase 3 trial targeting the H5N1 bird flu strain. The study will test safety and immune response in about 4,000 ...

The treatment staved off cancer for seven of eight patients with a condition where the odds are rarely that good.